Crinetics Pharmaceuticals, Inc. — Form 8-K
Filed August 14, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 5/100
What the filing says
Crinetics Pharmaceuticals filed a Form 8-K on 2026-08-14 for period ending 2026-08-12, containing only Item 8.01 (Other Events). No substantive details, dollar amounts, counterparties, dates, or business developments are disclosed in the filing header or document index provided. The actual content of the Other Events disclosure is not present in the text supplied.
Why this rating
Filing metadata only, no material facts disclosed. Cannot assess business impact without actual 8-K content.
Extracted items
See more from August 14, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.